3Takasu T, Ukai M, Sato S, et al. Effect of(R) -2-( 2-amin- othiazol-4-yl ) -4' - 1 2-[ ( 2-hydroxy-2-phenylethyl ) amino ] ethyl I acetanilide ( YMI78 ) , a novel selective/33-adreno- ceptor agonist, on bladder function [ J ]. J Pharmacol Exp Ther, 2007,321 ( 2 ) : 642-647.
4Takusagawa S, Van L, Jan J, et al. Absorption, metabolism and excretion of[ ~4 C ] mirabegron ( YM178 ), a potent and selective 133-adrenoceptor agonist, after oral administration to hea]thy m~e volunteers[ J]. Druge Metab Dispos,2012, 40(4) :815-824.
5Kawazoe S, Sakamoto K, Awamura Y, et al. Alpha-form or beta-form crystal of acetanilide derivative [ P ]. EP: 1440969,2002 - 10 -29.
8Brian M A, Richard G Y, Smith K, et al. Selective reduc- tion of nitroarylalkylnitriles with hydrazine and a metal catalyst[J]. Tetrahedron Lett, 1984,25 (45) :5 219-5 222.
9Hiroaki K, Kyoko K, Hiromichi S, et al. Activation of elec- trophilicity of stable y-delocalized carbamate cations in in-tramolecular aromatic substitution reaction: evidence for formation of diprotonated carbamates leading to generation of isocyanates[J]. J Org Chem,2012,77:9 313-9 328.
10Atsuko N, Tadahiro K. Studies of reduction with dime- thoxyborane-transition metal salt systems. I ~ reduction of nitriles, aldehydes and ketones with dimethoxyborane- transition metal salt systems [ J ]. Chem Pharm Bull, 1989,37(3) :808-810.
